EPI Program Achievements

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01CD02	TAXOTERE	B	Docetaxel (trihydrated) - 20mg/ml	20mg/ml	Injectable concentrated solution+diluent	6,574,078 L.L
L01CD02	TAXOTERE	B	Docetaxel (trihydrated) - 20mg/ml	20mg/ml	Injectable concentrated solution+diluent	6,574,078 L.L
L01AX03	TEMODAL	B	Temozolomide - 250mg	250mg	Capsule	18,516,505 L.L
L01AX03	TEGOZOL	G	Temozolomide - 250mg	250mg	Capsule	24,856,894 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 250mg	250mg	Capsule, hard	13,397,927 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMODAL	B	Temozolomide - 100mg	100mg	Capsule	7,731,224 L.L
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,012,533 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 100mg	100mg	Capsule, hard	4,511,279 L.L
L01AX03	TEMODAL	B	Temozolomide - 20mg	20mg	Capsule	1,612,611 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 20mg	20mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 20mg	20mg	Capsule, hard	920,532 L.L
L01AX03	TEGOZOL	G	Temozolomide - 20mg	100mg	Capsule	1,022,664 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AC01	TEPADINA	G	Thiotepa - 100mg	100mg	Injectable powder for concentrate for solution	98,197,306 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
J07AP03	TYPHIM VI	B	Salmonella typhi polysaccharides - 0.025mg/0.5ml	0.025mg/0.5ml	Injectable solution	1,118,077 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L
J06BB02	TETAGAM P	BioHuman	Human Tetanus Immunoglobulin - 250IU/ml	250IU/ml	Injectable solution	3,075,475 L.L
J06BB02	TETANUS GAMMA	BioHuman	Human Tetanus Immunoglobulin - 250IU/ml	250IU/ml	Injectable solution	3,077,399 L.L
J05AX12	TIVICAY	B	Dolutegravir - 50mg	50mg	Tablet, film coated	54,508,037 L.L
J05AR13	TRIUMEQ	B	Dolutegravir - 50mg, Abacavir sulfate - 600mg, Lamivudine - 300mg		Tablet, film coated	74,756,237 L.L
J05AR12	TELADINE	G	Lamivudine - 300mg, Tenofovir disoproxil fumarate - 300mg		Tablet	17,454,739 L.L
J05AR03	TRUVADA	B	Emtricitabine - 200mg, Tenofovir disoproxil - 245mg		Tablet, film coated	21,319,383 L.L
J05AH02	TAMIFLU	B	Oseltamivir (phosphate) - 75mg	75mg	Capsule	1,464,788 L.L
J05AH02	TAMIFLU	B	Oseltamivir (phosphate) - 75mg	75mg	Capsule	1,464,788 L.L
J05AF07	TENOFOVIR DISOPROXIL ARROW	G	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	9,747,613 L.L
J05AF07	TENOFOVIR DISOPROXIL BIOGARAN	G	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	9,747,613 L.L

إنجازات البرنامج